Seroindeterminate HTLV-1 prevalence and characteristics in blood donors in Taiwan

被引:27
|
作者
Lu, SC
Chen, BH
机构
[1] Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung 807, Taiwan
[2] Tainan Blood Ctr, Tainan, Taiwan
关键词
HTLV-1; indeterminate; donors;
D O I
10.1007/BF02982654
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Human T-cell leukemia virus type 1 (HTLV-1) is commonly accepted as the cause of adult T-cell leukemia and tropical spastic paraparesis/HTLV-1-associated myelopathy. Screening of blood donors for HTLV-1 and HTLV-2 was implemented in Taiwan in February 1996. From February 1996 to December 1998, we investigated the seroprevalence of HTLV-1 in all unpaid blood donors in Taiwan. Of 2,578,238 donors in all 6 blood centers, 1793 (0.06%) were seropositive for HTLV-1, and 605 (0.023%) were indeterminate for HTLV-1. Among these indeterminate donors, 359 (59.3%) were male. The most common HTLV-1-indeterminate pattern by Western blot in our study was GD21 alone (34.6%) followed by p24 alone (7.8%), p53 alone (6.5%), and gp46 + GD21 (6.0%). That GD21 pattern was found in 59.6% of indeterminate results in this study suggested that the majority of nonspecific enzyme immunoassay reactions were probably precipitated by viral envelop glycoprotein GD21. (C)2003 The Japanese Society of Hematology.
引用
收藏
页码:412 / 413
页数:2
相关论文
共 50 条
  • [31] VERTICAL TRANSMISSION OF THE HTLV-1
    DENIS, F
    VERDIER, M
    BONIS, J
    PATHOLOGIE BIOLOGIE, 1992, 40 (07): : 714 - 719
  • [32] HTLV-1 and Innate Immunity
    Journo, Chloe
    Mahieux, Renaud
    VIRUSES-BASEL, 2011, 3 (08): : 1374 - 1394
  • [33] HTLV-1: Persistence and pathogenesis
    Cook, Lucy B.
    Elemans, Marjet
    Rowan, Aileen G.
    Asquith, Becca
    VIROLOGY, 2013, 435 (01) : 131 - 140
  • [34] Updates on HTLV-1 Uveitis
    Kamoi, Koju
    Watanabe, Toshiki
    Uchimaru, Kaoru
    Okayama, Akihiko
    Kato, Seiko
    Kawamata, Toyotaka
    Kurozumi-Karube, Hisako
    Horiguchi, Noe
    Zong, Yuan
    Yamano, Yoshihisa
    Hamaguchi, Isao
    Nannya, Yasuhito
    Tojo, Arinobu
    Ohno-Matsui, Kyoko
    VIRUSES-BASEL, 2022, 14 (04):
  • [35] The Exceptional Oncogenicity of HTLV-1
    Tagaya, Yutaka
    Gallo, Robert C.
    FRONTIERS IN MICROBIOLOGY, 2017, 8
  • [36] Modulation of T cell responses in HTLV-1 carriers and in patients with myelopathy associated with HTLV-1
    Santos, Silvane B.
    Porto, Aurelia F.
    Muniz, Andre Luiz
    Luna, Tania
    Nascimento, Marcia C.
    Guerreiro, Jaqueline B.
    Oliveira-Filho, Jamary
    Morgan, Daniel J.
    Carvalho, Edgar M.
    NEUROIMMUNOMODULATION, 2006, 13 (03) : 145 - 151
  • [37] Prevalence of HTLV-I virus in blood donors and transfusion in Mali: Implications for blood safety
    Diarra, A. B.
    Kouriba, B.
    Guindo, A.
    Maiga, A. I.
    Diabate, D. T.
    Douyon, I.
    Diawara, S. I.
    Toure, B. A.
    Fonkoro, S.
    Murphy, E. L.
    Diallo, D. A.
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2014, 21 (03) : 139 - 142
  • [38] Comparative virology of HTLV-1 and HTLV-2
    Michael P. Martinez
    Jacob Al-Saleem
    Patrick L. Green
    Retrovirology, 16
  • [39] Comparative virology of HTLV-1 and HTLV-2
    Martinez, Michael P.
    Al-Saleem, Jacob
    Green, Patrick L.
    RETROVIROLOGY, 2019, 16 (01)
  • [40] Cellular immune response to HTLV-1
    Bangham, CRM
    Osame, M
    ONCOGENE, 2005, 24 (39) : 6035 - 6046